Exponent, Inc. (NASDAQ:EXPO) – Research analysts at Cantor Fitzgerald upped their FY2019 EPS estimates for shares of Exponent in a research report issued on Friday, July 19th, according to Zacks Investment Research. Cantor Fitzgerald analyst J. Foresi now expects that the business services provider will post earnings per share of $1.49 for the year, up from their previous estimate of $1.43. Cantor Fitzgerald has a “Overweight” rating and a $73.00 price target on the stock. Cantor Fitzgerald also issued estimates for Exponent’s FY2020 earnings at $1.63 EPS.
Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, July 18th. The business services provider reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.06. Exponent had a net margin of 19.64% and a return on equity of 23.44%. The business had revenue of $106.50 million during the quarter, compared to analysts’ expectations of $95.77 million. During the same period last year, the company posted $0.34 EPS. The business’s revenue was up 11.4% on a year-over-year basis.
A number of other equities analysts have also recently commented on the stock. Zacks Investment Research raised shares of Exponent from a “hold” rating to a “strong-buy” rating and set a $76.00 price target for the company in a research note on Monday, July 22nd. BidaskClub raised shares of Exponent from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. William Blair reaffirmed a “market perform” rating on shares of Exponent in a research note on Monday, April 22nd. SunTrust Banks set a $70.00 price target on shares of Exponent and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, ValuEngine cut shares of Exponent from a “hold” rating to a “sell” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $73.00.
Shares of NASDAQ:EXPO opened at $66.77 on Monday. Exponent has a 52 week low of $44.44 and a 52 week high of $70.19. The stock has a market cap of $3.49 billion, a PE ratio of 53.42 and a beta of 0.43. The business has a fifty day simple moving average of $62.17. The company has a quick ratio of 4.22, a current ratio of 3.60 and a debt-to-equity ratio of 0.05.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be issued a dividend of $0.16 per share. The ex-dividend date is Thursday, September 5th. This represents a $0.64 dividend on an annualized basis and a yield of 0.96%. Exponent’s payout ratio is 51.20%.
Institutional investors and hedge funds have recently made changes to their positions in the stock. National Asset Management Inc. purchased a new stake in Exponent during the 2nd quarter worth approximately $263,000. State Board of Administration of Florida Retirement System grew its position in Exponent by 3.7% during the 2nd quarter. State Board of Administration of Florida Retirement System now owns 19,754 shares of the business services provider’s stock worth $1,156,000 after purchasing an additional 710 shares during the last quarter. EULAV Asset Management grew its position in Exponent by 12.9% during the 2nd quarter. EULAV Asset Management now owns 162,600 shares of the business services provider’s stock worth $9,519,000 after purchasing an additional 18,600 shares during the last quarter. Conestoga Capital Advisors LLC grew its position in Exponent by 4.4% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,422,012 shares of the business services provider’s stock worth $141,785,000 after purchasing an additional 102,845 shares during the last quarter. Finally, Hillsdale Investment Management Inc. grew its position in Exponent by 6.8% during the 2nd quarter. Hillsdale Investment Management Inc. now owns 54,600 shares of the business services provider’s stock worth $3,197,000 after purchasing an additional 3,500 shares during the last quarter. Institutional investors own 88.42% of the company’s stock.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.